Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 29, 2002
Validation and application of an assay for the determination of mevalonic acid in human plasma by liquid chromatography tandem mass spectrometry
Mohammed Abrar, Paul D Martin
British Journal of Clinical Pharmacology
|
November 26, 2002
Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers
Paul D Martin, Patrick D Mitchell, Dennis W Schneck
Journal of Pharmaceutical and Biomedical Analysis
|
May 13, 2004
Quantification of the N-desmethyl metabolite of rosuvastatin in human plasma by automated SPE followed by HPLC with tandem MS detection
Caroline K Hull, Paul D Martin, Michael J Warwick, et al.
The Analyst
|
May 14, 2003
Comparison of normal and reversed-phase solid phase extraction methods for extraction of beta-blockers from plasma using molecularly imprinted polymers
Paul D Martin, Graeme R Jones, Frances Stringer, et al.
International Journal of Pharmaceutics
|
March 12, 2015
Inter-subject variability in intestinal drug solubility
Sarit Cohen Rabbie, Talia Flanagan, Paul D Martin, et al.
Clinical Therapeutics
|
September 27, 2003
A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers
Paul D Martin, Mike J Warwick, Aaron L Dane, et al.
Current Medical Research and Opinion
|
March 22, 2008
The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics
Paul D Martin, Dennis W Schneck, Aaron L Dane, et al.
Clinical Therapeutics
|
May 17, 2003
An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers
Paul D Martin, Aaron L Dane, Dennis W Schneck, et al.
Clinical Therapeutics
|
December 12, 2003
Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers
Paul D Martin, Mike J Warwick, Aaron L Dane, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 14, 2016
Estimating the variability in fraction absorbed as a paradigm for informing formulation development in early clinical drug development
Sarit Cohen Rabbie, Paul D Martin, Talia Flanagan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 29, 2002
Validation and application of an assay for the determination of mevalonic acid in human plasma by liquid chromatography tandem mass spectrometry
Mohammed Abrar, Paul D Martin
British Journal of Clinical Pharmacology
|
November 26, 2002
Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers
Paul D Martin, Patrick D Mitchell, Dennis W Schneck
Journal of Pharmaceutical and Biomedical Analysis
|
May 13, 2004
Quantification of the N-desmethyl metabolite of rosuvastatin in human plasma by automated SPE followed by HPLC with tandem MS detection
Caroline K Hull, Paul D Martin, Michael J Warwick, et al.
The Analyst
|
May 14, 2003
Comparison of normal and reversed-phase solid phase extraction methods for extraction of beta-blockers from plasma using molecularly imprinted polymers
Paul D Martin, Graeme R Jones, Frances Stringer, et al.
International Journal of Pharmaceutics
|
March 12, 2015
Inter-subject variability in intestinal drug solubility
Sarit Cohen Rabbie, Talia Flanagan, Paul D Martin, et al.
Clinical Therapeutics
|
September 27, 2003
A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers
Paul D Martin, Mike J Warwick, Aaron L Dane, et al.
Current Medical Research and Opinion
|
March 22, 2008
The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics
Paul D Martin, Dennis W Schneck, Aaron L Dane, et al.
Clinical Therapeutics
|
May 17, 2003
An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers
Paul D Martin, Aaron L Dane, Dennis W Schneck, et al.
Clinical Therapeutics
|
December 12, 2003
Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers
Paul D Martin, Mike J Warwick, Aaron L Dane, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 14, 2016
Estimating the variability in fraction absorbed as a paradigm for informing formulation development in early clinical drug development
Sarit Cohen Rabbie, Paul D Martin, Talia Flanagan, et al.
Page
of 3